Weekly Wrap: Competition Ahead for Johnson & Johnson
New drugs will pressure Johnson & Johnson; Netflix looks pricey; and Goldman goes direct to consumers.
Jeremy Glaser: Netflix soars, competition ahead for Johnson & Johnson, and Goldman goes direct to consumers. This time on the Morningstar Weekly Wrap.
Johnson & Johnson had slightly better than expected results. But Damien Conover sees competition looming.
Jeremy Glaser does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.